Glaucoma AI Detection: Does it Save Sight?

AI can now detect glaucoma from a fundus photograph with a sensitivity of over 90% — but the more important…

Cataract Surgery Does Not Protect You From Glaucoma

Cataract surgery can improve vision by removing a cloudy lens, but it does not prevent, cure, or eliminate the risk…

How Is Optic Nerve Damage Diagnosed Early?

Optic nerve damage is diagnosed early using tests like OCT scans and visual field testing to detect subtle structural and…

How I Think About Glaucoma

I think of glaucoma as a slow, silent risk to lifelong vision rather than just an eye pressure problem. The…

How I Think About Eye Care

How I Think About Eye Care

Many eye conditions that threaten vision do not cause symptoms early.
They progress quietly over years, and the loss they cause is often irreversible.

Because of this, my approach to eye care is built around thinking ahead, not reacting late.

At the centre of every decision is a simple principle: first, do no harm.
Each recommendation is guided by careful risk–benefit analysis, with a focus on long-arc vision preservation, quality of vision, and quality of life.

I focus on understanding risk before damage occurs, and on making decisions that still make sense many years from now. Vision is not just a number on a report: it is a lifelong function that shapes how you read, drive, work, and live independently.

Good eye care is not about doing more or acting faster.
It is about doing the right thing at the right time, with clarity.

I do not rush to surgery simply because it is available. I recommend it when careful assessment shows that not intervening carries a greater long-term risk than intervening, and when acting at the right moment offers the best chance of preserving function.

My role is not only to treat disease, but to help you make calm, informed decisions in situations where timing matters and vision must be protected for life.

Please also read What I Do, What I Don’t Do, and Who Should See Me

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1590+ patient reviews on Google.

Why Patients Trust Dr. Shibal Bhartiya

Clinical Leadership

Director, Department of Ophthalmology, Marengo Asia Hospitals
Former Director, Fortis Memorial Research Institute

International Expertise

Mayo Clinic Research Collaborator
AIIMS, New Delhi: Glaucoma, Cornea, and Ocular Surface Diseases
University of Geneva: Clinical Fellowship in Glaucoma, Dept of Clinical Neurosciences

Academic Leadership

Editor-in-Chief, Clinical and Experimental Vision & Eye Research
Executive Editor, Journal of Current Glaucoma Practice
200+ Publications
28 Textbooks

Evidence-Based Care

Independent second opinions
Patient-centred decisions
Personalised, ethical glaucoma care

Community Leadership

Program Director, MAIINS
Program Director, Community Outreach & Wellness
Founder, Vision Unlimited

Patient Confidence

1,590+ five-star Google review